Search
for

    Glossary Teratogenicity

    ability of a substance to cause birth defects

    Teratogenicity refers to the ability of a substance to cause birth defects or developmental malformations in a developing embryo or fetus. This can occur when a pregnant woman is exposed to certain drugs, chemicals, or environmental factors that interfere with normal fetal development, potentially leading to physical or functional abnormalities in the newborn.

    Research 10 of 320

    1. Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review Journal of The American Academy of Dermatology · 2018 · 18 citations
    2. Valproic acid teratogenicity in whole embryo culture is not prevented by zinc supplementation Biochemical Pharmacology · 1986 · 16 citations
    3. Apoptosis May Explain the Pharmacological Mode of Action and Adverse Effects of Isotretinoin, Including Teratogenicity Acta dermato-venereologica · 2017 · 66 citations
    4. Use of chemotherapy during human pregnancy Lancet Oncology · 2004 · 724 citations
    5. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology British Journal of Dermatology · 2010 · 136 citations
    6. Isotretinoin treatment of acne and related disorders: An update Journal of The American Academy of Dermatology · 1983 · 126 citations
    7. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010 British Journal of Dermatology · 2010 · 98 citations
    8. Management of acne Canadian Medical Association Journal · 2011 · 78 citations
    9. Oral isotretinoin for acne Cochrane library · 2018 · 58 citations
    10. Management of Hirsutism American journal of clinical dermatology · 2000 · 55 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →